Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
Addeli Bez Batti Angulski
,
Nora Hosny
,
Houda Cohen
, Ashley A. Martin
, Dongwoo Hahn
, Jack Bauer
,
Joseph M. Metzger
Physiology
Research output
:
Contribution to journal
›
Review article
›
peer-review
155
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Duchenne muscular dystrophy: disease mechanism and therapeutic strategies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Duchenne muscular Dystrophy
100%
Therapeutic Strategies
100%
Disease Mechanisms
100%
Disease Therapeutics
100%
Dystrophin
25%
Dystrophin Gene
25%
Inflammation
12%
Clinical Trials
12%
Cardiomyopathy
12%
Fibrosis
12%
Lessons Learned
12%
Gene Replacement
12%
Human Genetics
12%
Human Physiology
12%
Fatal Infection
12%
Respiratory Insufficiency
12%
Genetic Defects
12%
Human Trials
12%
First Section
12%
Striated muscle
12%
Membrane Stability
12%
Muscle Membrane
12%
Membrane Instability
12%
Muscle Physiology
12%
Skeletal muscle Wasting
12%
Pathophysiological Basis
12%
Pharmacology, Toxicology and Pharmaceutical Science
Duchenne Muscular Dystrophy
100%
Diseases
100%
Dystrophin
50%
Clinical Trial
25%
Genetic Disorder
12%
Muscle Atrophy
12%
Myocardial Disease
12%
Inflammation
12%
Respiratory Failure
12%
Fibrosis
12%
Pathogenesis
12%
Neuroscience
Muscular Dystrophy
100%
Dystrophin
50%
Genetics
25%
Skeletal Muscle
12%
Muscle Fiber Membrane
12%
Muscle Atrophy
12%
Myocardial Disease
12%
Immunology and Microbiology
Dystrophin
100%
Inflammation
25%
Skeletal Muscle
25%
Striated Muscle
25%
Muscle Fiber Membrane
25%
Psychology
Duchenne Muscular Dystrophy
100%
Clinical Trial
25%